BrainsWay’s flagship technology — Deep Transcranial Magnetic Stimulation (Deep TMS) – is broadening and deepening the capabilities of TMS beyond what is currently thought possible.

BrainsWay is continuously seeking to expand its platform, achieving outcomes that surpass traditional medical solutions. Through ongoing investment in R&D and in research initiatives ranging from large-scale multicenter trials to personalized medical studies, BrainsWay represents the next-generation of treatment options for Major Depression and OCD.

Well-positioned as a leader in this rapidly-expanding field, BrainsWay is changing the future of mental health.